Research
The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers
Alissa J. Wright, Tara Gomes, Muhammad M. Mamdani, John R. Horn and David N. Juurlink
CMAJ February 22, 2011 183 (3) 303-307; DOI: https://doi.org/10.1503/cmaj.100702
Alissa J. Wright
Tara Gomes
Muhammad M. Mamdani
John R. Horn
David N. Juurlink

Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers
Alissa J. Wright, Tara Gomes, Muhammad M. Mamdani, John R. Horn, David N. Juurlink
CMAJ Feb 2011, 183 (3) 303-307; DOI: 10.1503/cmaj.100702
Jump to section
Related Articles
- No related articles found.
Cited By...
- Concurrent use of opioids and benzodiazepines/Z-drugs in Alberta, Canada and the risk of hospitalisation and death: a case cross-over study
- Revisiting the drug interaction between tamoxifen and SSRI antidepressants
- Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study
- The cardiovascular safety of azithromycin
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions
- Risk of hypotension with concomitant use of calcium-channel blockers and macrolide antibiotics